Outcomes at 2 Years of Age after Repeat Doses of Antenatal Corticosteroids

2007290 citationsJournal Articlebronze Open Access

Authors

Caroline A Crowther · Women's and Children's Hospital

Lex W. Doyle · University of Melbourne

Ross Haslam · Women's and Children's Hospital

Janet E. Hiller · University of Adelaide

Jane E. Harding · University of Auckland

Jeffrey S. Robinson · University of Adelaide

Abstract

Administration of repeat doses of antenatal corticosteroids reduces neonatal morbidity without changing either survival free of major neurosensory disability or body size at 2 years of age. (Current Controlled Trials number, ISRCTN48656428 [controlled-trials.com].).

Topics & Keywords

Neonatal Respiratory Health Research Birth, Development, and Health Infant Development and Preterm Care

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 357, Issue 12, pp. 1179-1189

DOI: 10.1056/nejmoa071152

Field-Weighted Citation Impact: 18.99